- Home
- QNRX vs LICN Comparison
QNRX vs LICN Comparison
Compare QNRX & LICN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNRX
- LICN
- Stock Information
- Founded
- QNRX 2018
- LICN 2004
- Country
- QNRX United States
- LICN China
- Employees
- QNRX N/A
- LICN N/A
- Industry
- QNRX Medical/Dental Instruments
- LICN
- Sector
- QNRX Health Care
- LICN
- Exchange
- QNRX Nasdaq
- LICN Nasdaq
- Market Cap
- QNRX 2.5M
- LICN 2.1M
- IPO Year
- QNRX N/A
- LICN 2023
- Fundamental
- Price
- QNRX $7.12
- LICN $3.83
- Analyst Decision
- QNRX
- LICN
- Analyst Count
- QNRX 0
- LICN 0
- Target Price
- QNRX N/A
- LICN N/A
- AVG Volume (30 Days)
- QNRX 355.0K
- LICN 87.9K
- Earning Date
- QNRX 05-08-2025
- LICN 01-01-0001
- Dividend Yield
- QNRX N/A
- LICN N/A
- EPS Growth
- QNRX N/A
- LICN 36.90
- EPS
- QNRX N/A
- LICN 55.10
- Revenue
- QNRX N/A
- LICN $41,929,000.00
- Revenue This Year
- QNRX N/A
- LICN N/A
- Revenue Next Year
- QNRX N/A
- LICN N/A
- P/E Ratio
- QNRX N/A
- LICN $0.06
- Revenue Growth
- QNRX N/A
- LICN 24.86
- 52 Week Low
- QNRX $5.01
- LICN $0.04
- 52 Week High
- QNRX $54.95
- LICN $7.55
- Technical
- Relative Strength Index (RSI)
- QNRX 46.54
- LICN 55.91
- Support Level
- QNRX $5.27
- LICN $2.60
- Resistance Level
- QNRX $7.22
- LICN $3.70
- Average True Range (ATR)
- QNRX 1.12
- LICN 0.47
- MACD
- QNRX 0.22
- LICN -0.02
- Stochastic Oscillator
- QNRX 62.79
- LICN 61.50
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
About LICN Lichen China Limited
Lichen International Ltd formerly Lichen China Ltd is a holding company. The company, along with its subsidiaries provides financial and taxation solution services; education support services; and software and maintenance services. The company generates Majority revenue from Financial and taxation solution services.